TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Transcervical Foley Catheter With and Without Extra-Amniotic Saline Infusion for Labor Induction
Brief Summary: The purpose of this study is to compare the efficacy of a transcervical Foley catheter with and without extra-amniotic saline infusion (EASI) for priming the cervix for labor.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Foley catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Atad catheter | Intervention Type: DEVICE; Name: Foley catheter; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Atad catheter; Assigned to Arm(s): 2
B: Arm Label: folye catheter plus vaginal IMN; Type: EXPERIMENTAL; Interventions: Device: foley catheter, Drug: Vaginal IMN | Arm Label: Misoprostol vaginally; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DEVICE; Name: foley catheter; Assigned to Arm(s): folye catheter plus vaginal IMN | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol vaginally | Intervention Type: DRUG; Name: Vaginal IMN; Assigned to Arm(s): folye catheter plus vaginal IMN
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: dinoprostone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Device: Bard Catheter (balloon catheter) | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: dinoprostone; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Bard Catheter (balloon catheter); Assigned to Arm(s): 3
D: Intervention Type: DEVICE; Name: Transcervical Foley Catheter; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Transcervical Foley Catheter with an EASI; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndromes Randomized for an Immediate or Delayed Intervention (The ABOARD Study)
Brief Summary: Release of troponin evaluated by the peak of troponin during the hospital phase.Because of its sensitivity and specificity as well as its widespread use in routine practice, rise in troponin levels is the main assessment criteria of this study. We plan to demonstrate a significantly altered distribution of the troponin release as evaluated by the peak of troponin for each patient during the hospitalization period (from randomization to cardiologic unit discharge), in the two arms of the trial.


Options:
A: Arm Label: Eptifibatide; Type: EXPERIMENTAL; Interventions: Drug: Eptifibatide (Integrilin) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Eptifibatide (Integrilin); Assigned to Arm(s): Eptifibatide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Angiomax (bivalirudin) anticoagulant; Assigned to Arm(s): N/A
C: Arm Label: Immediate Intervention; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Timing of percutaneous coronary intervention | Arm Label: Early Intervention; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Timing of percutaneous coronary intervention | Arm Label: Selective invasive angiography; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Timing of percutaneous coronary intervention | Intervention Type: PROCEDURE; Name: Timing of percutaneous coronary intervention; Assigned to Arm(s): Early Intervention, Immediate Intervention, Selective invasive angiography
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Catheterization immediate PCI | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: delayed PCI | Intervention Type: PROCEDURE; Name: Catheterization immediate PCI; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: delayed PCI; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An International, Multicentre, Randomised, Double-blind, Placebo-controlled, Two-parallel Group, Phase III Study to Evaluate the Efficacy and Safety of ARIXTRA (2.5mg Subcutaneously) for the Treatment of Patients With Acute Symptomatic Isolated Superficial Thrombophlebitis of the Lower Limbs to Prevent Thromboembolic Complications
Brief Summary: To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.


Options:
A: Arm Label: fondaparinux; Type: EXPERIMENTAL; Interventions: Drug: fondaparinux | Intervention Type: DRUG; Name: fondaparinux; Assigned to Arm(s): fondaparinux
B: Arm Label: Idrabiotaparinux; Type: EXPERIMENTAL; Interventions: Drug: Idrabiotaparinux sodium, Drug: Avidin, Drug: Placebo (for warfarin), Drug: Enoxaparin | Arm Label: Warfarin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Warfarin, Drug: Placebo (for idrabiotaparinux sodium), Drug: Avidin, Drug: Enoxaparin | Intervention Type: DRUG; Name: Idrabiotaparinux sodium; Assigned to Arm(s): Idrabiotaparinux | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Placebo (for idrabiotaparinux sodium); Assigned to Arm(s): Warfarin | Intervention Type: DRUG; Name: Avidin; Assigned to Arm(s): Idrabiotaparinux, Warfarin | Intervention Type: DRUG; Name: Placebo (for warfarin); Assigned to Arm(s): Idrabiotaparinux | Intervention Type: DRUG; Name: Enoxaparin; Assigned to Arm(s): Idrabiotaparinux, Warfarin
C: Arm Label: Fondaparinux; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fondaparinux | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Fondaparinux; Assigned to Arm(s): Fondaparinux | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Fondaparinux 2.5mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fondaparinux 2.5mg or placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Fondaparinux 2.5mg or placebo | Intervention Type: DRUG; Name: Fondaparinux 2.5mg or placebo; Assigned to Arm(s): Fondaparinux 2.5mg, Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An International, Multicentre, Randomised, Double-blind, Placebo-controlled, Two-parallel Group, Phase III Study to Evaluate the Efficacy and Safety of ARIXTRA (2.5mg Subcutaneously) for the Treatment of Patients With Acute Symptomatic Isolated Superficial Thrombophlebitis of the Lower Limbs to Prevent Thromboembolic Complications
Brief Summary: To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.


Options:
A: Arm Label: Ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dalteparin sodium injection | Intervention Type: DRUG; Name: Dalteparin sodium injection; Assigned to Arm(s): Ibuprofen
B: Arm Label: dalteparin 5000 I.U./24 h s.c.; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dalteparin | Arm Label: dalteparin 15000 I.U./24 h s.c.; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dalteparin | Intervention Type: DRUG; Name: Dalteparin; Assigned to Arm(s): dalteparin 5000 I.U./24 h s.c. | Intervention Type: DRUG; Name: Dalteparin; Assigned to Arm(s): dalteparin 15000 I.U./24 h s.c.
C: Arm Label: 1; Type: N/A; Interventions: Procedure: compression ultrasonography at 3 months | Arm Label: 2; Type: N/A; Interventions: N/A | Intervention Type: PROCEDURE; Name: compression ultrasonography at 3 months; Assigned to Arm(s): 1
D: Arm Label: Fondaparinux 2.5mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fondaparinux 2.5mg or placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Fondaparinux 2.5mg or placebo | Intervention Type: DRUG; Name: Fondaparinux 2.5mg or placebo; Assigned to Arm(s): Fondaparinux 2.5mg, Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With Melphalan/Prednisone/Velcade Versus Thalidomide / Prednisone / Velcade and Maintenance Treatment With Thalidomide / Velcade Versus Prednisone / Velcade in Untreated Patients With Multiple Myeloma More Than 65 Years Old.
Brief Summary: The primary objective is to analyze and compare the efficacy, the response rate, the CR and the response rate duration of both induction treatments and both maintenance treatments


Options:
A: Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): N/A
C: Arm Label: Part 1: VMP+Siltuximab 11 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Siltuximab11 mg/kg, Drug: Velcade (bortezomib), Drug: Melphalan, Drug: Prednisone | Arm Label: Part 2, Arm A: VMP+Siltuximab 8.3 mg/kg or 11 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Siltuximab 8.3 mg/kg or 11 mg/kg, Drug: Velcade (bortezomib), Drug: Melphalan, Drug: Prednisone | Arm Label: Part 2, Arm B: VMP; Type: ACTIVE_COMPARATOR; Interventions: Drug: Velcade (bortezomib), Drug: Melphalan, Drug: Prednisone | Intervention Type: DRUG; Name: Siltuximab11 mg/kg; Assigned to Arm(s): Part 1: VMP+Siltuximab 11 mg/kg | Intervention Type: DRUG; Name: Siltuximab 8.3 mg/kg or 11 mg/kg; Assigned to Arm(s): Part 2, Arm A: VMP+Siltuximab 8.3 mg/kg or 11 mg/kg | Intervention Type: DRUG; Name: Velcade (bortezomib); Assigned to Arm(s): Part 1: VMP+Siltuximab 11 mg/kg | Intervention Type: DRUG; Name: Velcade (bortezomib); Assigned to Arm(s): Part 2, Arm A: VMP+Siltuximab 8.3 mg/kg or 11 mg/kg | Intervention Type: DRUG; Name: Melphalan; Assigned to Arm(s): Part 1: VMP+Siltuximab 11 mg/kg | Intervention Type: DRUG; Name: Melphalan; Assigned to Arm(s): Part 2, Arm A: VMP+Siltuximab 8.3 mg/kg or 11 mg/kg | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Part 1: VMP+Siltuximab 11 mg/kg | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Part 2, Arm A: VMP+Siltuximab 8.3 mg/kg or 11 mg/kg | Intervention Type: DRUG; Name: Velcade (bortezomib); Assigned to Arm(s): Part 2, Arm B: VMP | Intervention Type: DRUG; Name: Melphalan; Assigned to Arm(s): Part 2, Arm B: VMP | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Part 2, Arm B: VMP
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Melphalan/Prednisone/Velcade | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Thalidomide/Prednisone/Velcade | Intervention Type: DRUG; Name: Melphalan/Prednisone/Velcade; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Thalidomide/Prednisone/Velcade; Assigned to Arm(s): B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With Melphalan/Prednisone/Velcade Versus Thalidomide / Prednisone / Velcade and Maintenance Treatment With Thalidomide / Velcade Versus Prednisone / Velcade in Untreated Patients With Multiple Myeloma More Than 65 Years Old.
Brief Summary: The primary objective is to analyze and compare the efficacy, the response rate, the CR and the response rate duration of both induction treatments and both maintenance treatments


Options:
A: Arm Label: carfilzomib (A0); Type: EXPERIMENTAL; Interventions: Drug: carfilzomib | Arm Label: carfilzomib (A1); Type: EXPERIMENTAL; Interventions: Drug: carfilzomib | Intervention Type: DRUG; Name: carfilzomib; Assigned to Arm(s): carfilzomib (A0) | Intervention Type: DRUG; Name: carfilzomib; Assigned to Arm(s): carfilzomib (A1)
B: Arm Label: VELCADE (bortezomib) monotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bortezomib (VELCADE) | Arm Label: DOXIL/CAELYX in combination with VELCADE (bortezomib); Type: EXPERIMENTAL; Interventions: Drug: Bortezomib (VELCADE), Drug: Doxorubicin hydrochloride (DOXIL/CAELYX) | Intervention Type: DRUG; Name: Bortezomib (VELCADE); Assigned to Arm(s): VELCADE (bortezomib) monotherapy | Intervention Type: DRUG; Name: Bortezomib (VELCADE); Assigned to Arm(s): DOXIL/CAELYX in combination with VELCADE (bortezomib) | Intervention Type: DRUG; Name: Doxorubicin hydrochloride (DOXIL/CAELYX); Assigned to Arm(s): DOXIL/CAELYX in combination with VELCADE (bortezomib)
C: Arm Label: VTD; Type: EXPERIMENTAL; Interventions: Drug: Velcade, Drug: Thalidomide, Drug: Dexamethasone, Procedure: Peripheral Blood Stem Cell (PBSC) collection, Procedure: First Autologous Transplantation, Procedure: Second Autologous Transplantation | Arm Label: TD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Thalidomide, Drug: Dexamethasone, Procedure: Peripheral Blood Stem Cell (PBSC) collection, Procedure: First Autologous Transplantation, Procedure: Second Autologous Transplantation | Intervention Type: DRUG; Name: Velcade; Assigned to Arm(s): VTD | Intervention Type: DRUG; Name: Thalidomide; Assigned to Arm(s): TD, VTD | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): TD, VTD | Intervention Type: PROCEDURE; Name: Peripheral Blood Stem Cell (PBSC) collection; Assigned to Arm(s): TD, VTD | Intervention Type: PROCEDURE; Name: First Autologous Transplantation; Assigned to Arm(s): TD, VTD | Intervention Type: PROCEDURE; Name: Second Autologous Transplantation; Assigned to Arm(s): TD, VTD
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Melphalan/Prednisone/Velcade | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Thalidomide/Prednisone/Velcade | Intervention Type: DRUG; Name: Melphalan/Prednisone/Velcade; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Thalidomide/Prednisone/Velcade; Assigned to Arm(s): B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double Blind, Placebo Controlled Study for the Study of the Effectiveness of Perioperative Analgesia in Phantom and Stump Pain
Brief Summary: Severe pre-amputation pain is associated with phantom pain development, and phantom pain models assign major importance to central and peripheral nervous system changes related to pre-amputation pain. Several interventions have been evaluated for phantom pain prevention, including continuous brachial plexus blockade5, intravenous6 or epidural ketamine administration, postoperative perineural ketamine/clonidine infusion8 and oral gabapentin9, but their true effect remains unclear.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: chirocaine (Levobupivacaine) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: sodium chloride | Intervention Type: DRUG; Name: chirocaine (Levobupivacaine); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: sodium chloride; Assigned to Arm(s): 2
B: Arm Label: 0.25% Ropivicaine; Type: EXPERIMENTAL; Interventions: Drug: Ropivicaine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline placebo | Intervention Type: DRUG; Name: Saline placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Ropivicaine; Assigned to Arm(s): 0.25% Ropivicaine
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Intervention Type: PROCEDURE; Name: perioperative epidural catheter; Assigned to Arm(s): 1, 2, 3, 4, 5
D: Arm Label: ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: infiltration with ropivacaine solution | Intervention Type: PROCEDURE; Name: infiltration with ropivacaine solution; Assigned to Arm(s): placebo, ropivacaine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double Blind, Placebo Controlled Study for the Study of the Effectiveness of Perioperative Analgesia in Phantom and Stump Pain
Brief Summary: Severe pre-amputation pain is associated with phantom pain development, and phantom pain models assign major importance to central and peripheral nervous system changes related to pre-amputation pain. Several interventions have been evaluated for phantom pain prevention, including continuous brachial plexus blockade5, intravenous6 or epidural ketamine administration, postoperative perineural ketamine/clonidine infusion8 and oral gabapentin9, but their true effect remains unclear.


Options:
A: Arm Label: Injection with Saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Infiltration with Saline | Arm Label: Injection with Bupivacaine; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Infiltration with Bupivacaine | Intervention Type: PROCEDURE; Name: Infiltration with Saline; Assigned to Arm(s): Injection with Saline | Intervention Type: PROCEDURE; Name: Infiltration with Bupivacaine; Assigned to Arm(s): Injection with Bupivacaine
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Intervention Type: PROCEDURE; Name: perioperative epidural catheter; Assigned to Arm(s): 1, 2, 3, 4, 5
C: Arm Label: Patients who had inguinal herniorraphy.; Type: N/A; Interventions: Procedure: Inguinal herniorraphy. | Arm Label: Patients who had hysterectomy.; Type: N/A; Interventions: Procedure: Hysterectomy. | Arm Label: Patients who had thoracotomy.; Type: N/A; Interventions: Procedure: Thoracotomy . | Intervention Type: PROCEDURE; Name: Inguinal herniorraphy.; Assigned to Arm(s): Patients who had inguinal herniorraphy. | Intervention Type: PROCEDURE; Name: Hysterectomy.; Assigned to Arm(s): Patients who had hysterectomy. | Intervention Type: PROCEDURE; Name: Thoracotomy .; Assigned to Arm(s): Patients who had thoracotomy.
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: chirocaine (Levobupivacaine) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: sodium chloride | Intervention Type: DRUG; Name: chirocaine (Levobupivacaine); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: sodium chloride; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double Blind, Placebo Controlled Study for the Study of the Effectiveness of Perioperative Analgesia in Phantom and Stump Pain
Brief Summary: Severe pre-amputation pain is associated with phantom pain development, and phantom pain models assign major importance to central and peripheral nervous system changes related to pre-amputation pain. Several interventions have been evaluated for phantom pain prevention, including continuous brachial plexus blockade5, intravenous6 or epidural ketamine administration, postoperative perineural ketamine/clonidine infusion8 and oral gabapentin9, but their true effect remains unclear.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vitamin Complex (placebo) | Arm Label: Pregabalin; Type: EXPERIMENTAL; Interventions: Drug: Pregabalin | Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): Pregabalin | Intervention Type: DRUG; Name: Vitamin Complex (placebo); Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Arm Label: 5; Type: PLACEBO_COMPARATOR; Interventions: Procedure: perioperative epidural catheter | Intervention Type: PROCEDURE; Name: perioperative epidural catheter; Assigned to Arm(s): 1, 2, 3, 4, 5
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: anti TNFa monoclonal antibody - Infliximab | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: anti TNFa monoclonal antibody - Infliximab; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: ropivacaine, ketorelac and epinephrine | Arm Label: P; Type: PLACEBO_COMPARATOR; Interventions: Drug: saline | Intervention Type: DRUG; Name: ropivacaine, ketorelac and epinephrine; Assigned to Arm(s): A | Intervention Type: DRUG; Name: saline; Assigned to Arm(s): P

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Longitudinal Follow Up of Subjects Enrolled in Randomized Trials of Prenatal and Infancy Home Visitation
Brief Summary: The Elmira follow-up study is designed to assess the extent to which prenatal and infancy home visitation by nurses affects the life-course development of 19-year-old youth whose mothers received those services during pregnancy and the first two years of the child's life.


Options:
A: Arm Label: Helping the Noncompliant Child (HNC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Helping the Noncompliant Child (HNC) | Arm Label: Technology-Enhanced HNC (TE-HNC); Type: EXPERIMENTAL; Interventions: Behavioral: Technology-Enhanced Helping the Noncompliant Child (TE-HNC) | Intervention Type: BEHAVIORAL; Name: Helping the Noncompliant Child (HNC); Assigned to Arm(s): Helping the Noncompliant Child (HNC) | Intervention Type: BEHAVIORAL; Name: Technology-Enhanced Helping the Noncompliant Child (TE-HNC); Assigned to Arm(s): Technology-Enhanced HNC (TE-HNC)
B: Arm Label: Behavioral Parent Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Behavioral Parent Training | Arm Label: Behavioral Parent Training - Enhanced; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Parent Training | Intervention Type: BEHAVIORAL; Name: Behavioral Parent Training; Assigned to Arm(s): Behavioral Parent Training, Behavioral Parent Training - Enhanced
C: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home visitation through pregnancy; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Arm Label: Home visitation through age 2; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Intervention Type: BEHAVIORAL; Name: nurse home visitation; Assigned to Arm(s): Home visitation through age 2, Home visitation through pregnancy
D: Arm Label: Usual Care control (Parenting tips); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Strongest Families; Type: EXPERIMENTAL; Interventions: Behavioral: Strongest Families | Intervention Type: BEHAVIORAL; Name: Strongest Families; Assigned to Arm(s): Strongest Families

Answer: C